- Home
- DSS vs CYCN Comparison
DSS vs CYCN Comparison
Compare DSS & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- CYCN
- Stock Information
- Founded
- DSS 1984
- CYCN 2018
- Country
- DSS United States
- CYCN United States
- Employees
- DSS N/A
- CYCN N/A
- Industry
- DSS Containers/Packaging
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- CYCN Health Care
- Exchange
- DSS Nasdaq
- CYCN Nasdaq
- Market Cap
- DSS 8.9M
- CYCN 6.5M
- IPO Year
- DSS N/A
- CYCN N/A
- Fundamental
- Price
- DSS $0.89
- CYCN $3.36
- Analyst Decision
- DSS
- CYCN
- Analyst Count
- DSS 0
- CYCN 0
- Target Price
- DSS N/A
- CYCN N/A
- AVG Volume (30 Days)
- DSS 187.4K
- CYCN 25.7K
- Earning Date
- DSS 08-12-2025
- CYCN 08-06-2025
- Dividend Yield
- DSS N/A
- CYCN N/A
- EPS Growth
- DSS N/A
- CYCN N/A
- EPS
- DSS N/A
- CYCN N/A
- Revenue
- DSS $20,180,000.00
- CYCN $2,081,000.00
- Revenue This Year
- DSS N/A
- CYCN N/A
- Revenue Next Year
- DSS N/A
- CYCN N/A
- P/E Ratio
- DSS N/A
- CYCN N/A
- Revenue Growth
- DSS 12.88
- CYCN N/A
- 52 Week Low
- DSS $0.72
- CYCN $1.27
- 52 Week High
- DSS $1.67
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- DSS 46.77
- CYCN 60.16
- Support Level
- DSS $0.88
- CYCN $3.02
- Resistance Level
- DSS $0.96
- CYCN $3.50
- Average True Range (ATR)
- DSS 0.07
- CYCN 0.26
- MACD
- DSS -0.00
- CYCN 0.03
- Stochastic Oscillator
- DSS 41.75
- CYCN 82.28
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.